Skip to content

US · LNAI · BIOTECHNOLOGY

Lunai Bioworks Inc. (LNAI) intrinsic value and stock valuation

$0.16as of 2026-11-21 · Mkt cap 11.24M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Lunai Bioworks Inc. DCF and intrinsic value

InvestorsCraft values LNAI with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from LNAI’s statements →

Lunai Bioworks Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Biotechnology Los Angeles, CA 90067 lunaibioworks.com

How the business is doing

Fiscal 2021–2025, USD

Revenue
$0.00
20212025
Net income
-$-178.01M
20212025
Free cash flow
-$-7.87M
20212025
Total equity
-$-21.35M
20212025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2021–2025, USD
20252024202320222021
Revenue$0.00$0.00$0.00$0.00$0.00
Operating income-$-18.55M-$-81.64M-$-38.56M-$-116.08M-$-23.4M
Net income-$-178.01M-$-88.43M-$-39.68M-$-113.43M-$-26.72M
EPSd-$-86.41M-$-72.48M-$-56.69M-$-171.86M-$-45.29M
Operating cash flow-$-7.87M-$-10.97M-$-11.77M-$-15.73M-$-20.61M
Capital expenditure-$0.00-$-70K-$-30K-$-10K-$-50K
Free cash flow-$-7.87M-$-11.04M-$-11.8M-$-15.74M-$-20.66M
Total assets$8.23M$163.1M$58.3M$84.6M$189.6M
Total debt$10.2M$3.79M$5.59M$7.02M$7.37M
Net debt$10.1M$3.57M$3.72M-$-2.16M-$-13.29M
Total equity-$-21.35M$132M$46.5M$72.6M$174.7M
Cash and short-term investments$480K$220K$1.87M$9.17M$20.7M
Income statement
20252024202320222021
Revenue$0.00$0.00$0.00$0.00$0.00
Cost of revenue$130K$0.00$0.00$0.00$390K
Gross profit-$-130K$0.00$0.00$0.00-$-390K
Research and development expenses$540K$2.71M$4.17M$8.37M$15.5M
Selling, general and administrative expenses$17.9M$24.6M$15.3M$14.3M$7.47M
Other expenses$0.00$54.4M$19.1M$93.4M$0.00
Operating expenses$18.4M$81.6M$38.6M$116.1M$23M
Cost and expenses$18.6M$81.6M$38.6M$116.1M$23.4M
Interest income$120K$0.00$0.00$120K$10K
Interest expense$730K$2.43M$710K$370K$380K
Depreciation and amortization$130K$120K$110K$120K$390K
Ebitda-$-177.15M-$-85.87M-$-38.86M-$-112.94M-$-26.08M
Operating income-$-18.55M-$-81.64M-$-38.56M-$-116.08M-$-23.4M
Total other income/expenses, net-$-159.46M-$-6.79M-$-1.13M$2.65M-$-3.45M
Income before tax-$-178.01M-$-88.43M-$-39.68M-$-113.43M-$-26.85M
Income tax expense$0.00$0.00$0.00$0.00-$-130K
Net income-$-178.01M-$-88.43M-$-39.68M-$-113.43M-$-26.72M
Weighted average shares outstanding$2.06M$1.22M$700K$660K$590K
Weighted average diluted shares outstanding$2.06M$1.22M$700K$660K$590K
Balance sheet
20252024202320222021
Cash and short-term investments$480K$220K$1.87M$9.17M$20.7M
Net receivables$0.00$1.11M$0.00$0.00$0.00
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$1.05M$2M$2.57M$9.57M$20.9M
Property, plant and equipment, net$1.06M$1.75M$1.42M$1.74M$2.16M
Goodwill and intangible assets$6.13M$159.4M$54.3M$73.3M$166.5M
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$7.18M$161.1M$55.7M$75.1M$168.7M
Total assets$8.23M$163.1M$58.3M$84.6M$189.6M
Accounts payable$12.6M$9.45M$5.3M$1.4M$320K
Short-term debt$9.75M$2.94M$4.82M$1.45M$350K
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$29.2M$30.3M$11M$6.45M$1.89M
Long-term debt$420K$840K$780K$5.56M$7.02M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$420K$840K$780K$5.56M$13.1M
Capital lease obligations$740K$1.34M$970K$1.24M$1.24M
Total liabilities$29.6M$31.2M$11.8M$12M$14.9M
Common stock$20K$20K$10K$10K$10K
Retained earnings-$-510.46M-$-332.46M-$-244.03M-$-204.35M-$-90.91M
Accumulated other comprehensive income (loss)$10.8M-$-170K-$-30K-$-30K-$-10K
Total equity-$-21.35M$132M$46.5M$72.6M$174.7M
Total investments$390K$0.00$0.00$0.00$0.00
Total debt$10.2M$3.79M$5.59M$7.02M$7.37M
Net debt$10.1M$3.57M$3.72M-$-2.16M-$-13.29M
Cash flow statement
20252024202320222021
Net income-$-178.01M-$-88.43M-$-39.68M-$-113.43M-$-26.72M
Depreciation and amortization$130K$120K$110K$120K$390K
Stock-based compensation$3.31M$4.67M$3.54M$5.49M$0.00
Change in working capital$5.86M$8.81M$4.31M$1.42M$930K
Accounts receivable$1.15M-$-1.11M$0.00$0.00$0.00
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$3.11M$4.06M$3.89M$1.08M-$-270K
Net cash provided by operating activities-$-7.87M-$-10.97M-$-11.77M-$-15.73M-$-20.61M
Investments in property, plant and equipment$0.00-$-70K-$-30K-$-10K-$-50K
Acquisitions, net$0.00-$-1.19M$0.00$0.00$0.00
Net cash used for investing activities-$-500K-$-1.26M-$-30K-$-10K-$-50K
Common stock issued$2.38M$3M$4.01M$4.68M$31.9M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$8.38M$10.5M$4.52M$4.25M$32.6M
Net change in cash-$-130K-$-1.65M-$-7.3M-$-11.49M$12M
Cash at end of period$90K$220K$1.87M$9.17M$20.7M
Operating cash flow-$-7.87M-$-10.97M-$-11.77M-$-15.73M-$-20.61M
Capital expenditure-$0.00-$-70K-$-30K-$-10K-$-50K
Free cash flow-$-7.87M-$-11.04M-$-11.8M-$-15.74M-$-20.66M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Lunai Bioworks Inc.

        Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."

        CEO
        David H. Weinstein
        Employees
        29
        Beta
        0.35

        Explore

        Frequently asked questions

        What is the intrinsic value of Lunai Bioworks Inc. (LNAI)?

        InvestorsCraft does not currently publish an intrinsic value for LNAI. How the IC value is calculated.

        Is LNAI undervalued?

        InvestorsCraft does not publish an undervaluation signal for LNAI at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.